Links on this page are about genetics information and MPNs.
More general MPN information is at the main MPN guidelines and articles page.
Genetics Information
- Life histories of myeloproliferative neoplasms inferred from phylogenies, Nature, 2022
- Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase, Nature, 2024
- Genetic basis and molecular profiling in myeloproliferative neoplasms, Blood, 2023
- Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement, Pathology, 2022
- Classification and Personalized Prognosis in Myeloproliferative Neoplasms, NEJM, 2018
- Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population, Blood, 2019
- ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera, Blood Advances (letter), 2022
- Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
- Genetics Home Reference – Your Guide to Understanding Genetic Conditions
- ET https://ghr.nlm.nih.gov/condition/essential-thrombocythemia
- PV https://ghr.nlm.nih.gov/condition/polycythemia-vera#resources
- MF https://ghr.nlm.nih.gov/condition/primary-myelofibrosis
Links to information on various genetic mutations
- JAK2 https://ghr.nlm.nih.gov/gene/JAK2
- CALR https://ghr.nlm.nih.gov/gene/CALR
- MPL https://ghr.nlm.nih.gov/gene/MPL#resources
- TET2 https://ghr.nlm.nih.gov/gene/TET2#conditions